Britons line up for share of largest lawsuit in history

The huge damages awarded by a US court against the drug company Merck could start a flood of legal claims around the world. Andrew Johnson reports on reactions in this country

On Friday, a Texas jury ordered Merck to pay $253m (£141m) to the widow of a man who died in his sleep from a Vioxx-induced heart attack. British legal firms are predicting that claims from this country alone will run into the thousands.

Vioxx was taken off the market last September after a long-term study found it increased the risk of heart attacks and strokes.

The court rejected Merck's argument that he died of clogged arteries. But Merck intends to appeal against the decision and has promised to fight up to 4,200 lawsuits from across America. It also faces claims from India, China, Canada and Italy.

More than 500,000 Britons had taken Vioxx, one of a new generation of painkillers known as Cox-2 inhibitors. They were seen as a breakthrough in relief for arthritis sufferers because they did not have the side effects of established remedies.

A 52-year-old woman from Skelmersdale, Lancashire has already begun filing court papers in the state of New Jersey, claiming the drug caused two strokes. Christine Peckham (below) is one of 150 people contemplating legal action before this weekend's publicity.

Russell Spargo, of the law firm MSB, which is representing 60 British claimants, said yesterday: "We've been inundated with calls, all of them potentially strong cases. It is believed to have caused 28,000 deaths in America alone. I believe this could be the biggest legal action ever."

Gerard Dervan, a partner in the Liverpool law firm MSB, which is representing Ms Peckham, along with 60 other potential claimants, said: "The process is under way. We have a US attorney lined up and the files are in transit.

"It could be years before this case is heard in the UK, and then the costs could be astronomical and we will receive no public funding. The American system is more geared up for claims of this kind and there it is no-win, no-fee."

He said it might be the case that the drug was not properly scrutinised in the UK. "Certainly here in England the drug was approved in four weeks by British authorities and one would have to surmise that they did not do adequate research into the safety of this drug," he said. "One just wonders whether or not the mighty dollar was more advantageous than people's health."

He also said that if Merck loses more lawsuits it will be forced to negotiate a compensation package.

It is expected, however, that Merck will challenge the US court's ability to hear claims from outside America. One of Merck's arguments is that the nature of the drug meant it was taken by elderly people, for whom a stroke or heart attack is already a risk.

Vioxx is a source of particular controversy because of claims that key medical data about the drug and other Cox-2 inhibitors has been suppressed by the US regulator, the powerful Food and Drug Administration.

Last year The Lancet published trial results showing that unacceptable heart risks linked to the drug rofecoxib (sold as Vioxx) were evident four years before it was finally withdrawn by its maker.

An investigation by The Independent on Sunday earlier this year showed how the interests of commercial confidentiality meant that even suicides associated with trials of the new antidepressant Cymbalta had been kept from the FDA records. These include the widely reported suicide of 19-year-old Traci Johnson, a volunteer who hanged herself in one of manufacturer Eli Lilly's own testing suites during a trial of Cymbalta.

'I feel bitter and very, very angry'

Christine Peckham, now 52, was in pain from osteoarthritis when her doctor first prescribed Vioxx four years ago.

At first she was delighted. "The arthritis was very painful," she says. "I'd tried other drugs, but asked my doctor for something else, and Vioxx was the new wonder drug. It eased the pain considerably."

Less than two years later, however, Christine suffered a stroke. She didn't drink or smoke, she wasn't overweight and didn't have high blood pressure - all potential causes of strokes - and nobody could tell her why she had suffered a stroke at such a young age.

"I had the mother of all headaches," she says. "I went to bed and when I woke up my left side was numb and the left side of my face had dropped. The stroke was quite severe.

"A few months later I had another stroke. That has left me paralysed and with tunnel vision and epilepsy. I couldn't believe what was happening to me."

Throughout this period she had continued to take Vioxx until her GP told her to stop taking it, as there had been "a few problems".

"That's when I found out it caused strokes and heart attacks. It has ruined my life. I'm not being dramatic when I say that. I'm not dead but it took my life away. I can't do the things I used to: I can't go out, I can't read the paper. It has to be read to me. I was quite active. All that's gone. I feel bitter and very angry.

"Merck knew what was going on seven months before my stroke - they had memos from the Federal Drug Authority - but they carried on and put profit before people's lives. They should be held accountable.

"I'll be on benefits for the rest of my life, and my husband can't work as he has to look after me. The British taxpayer has to pay. Why shouldn't Merck pay from all the profits they've made?"

Start your day with The Independent, sign up for daily news emails
News
Bill Gates, founder of Microsoft and co-chair of the Bill and Melinda Gates Foundation
businessUber, Snapchat and Facebook founders among those on the 2015 Forbes Billionaire List
News
news... and what your reaction to the creatures above says about you
News
Jihadi John
newsMonikers like 'Jihadi John' make the grim sound glamorous
News
music
ebooks
ebooksA special investigation by Andy McSmith
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

Day In a Page

The difference between America and Israel? There isn’t one

The difference between America and Israel? There isn’t one

Netanyahu knows he can get away with anything in America, says Robert Fisk
Families clubbing together to build their own affordable accommodation

Do It Yourself approach to securing a new house

Community land trusts marking a new trend for taking the initiative away from developers
Head of WWF UK: We didn’t send Cameron to the Arctic to see green ideas freeze

David Nussbaum: We didn’t send Cameron to the Arctic to see green ideas freeze

The head of WWF UK remains sanguine despite the Government’s failure to live up to its pledges on the environment
Author Kazuo Ishiguro on being inspired by shoot-outs and samurai

Author Kazuo Ishiguro on being inspired by shoot-outs and samurai

Set in a mythologised 5th-century Britain, ‘The Buried Giant’ is a strange beast
With money, corruption and drugs, this monk fears Buddhism in Thailand is a ‘poisoned fruit’

Money, corruption and drugs

The monk who fears Buddhism in Thailand is a ‘poisoned fruit’
America's first slavery museum established at Django Unchained plantation - 150 years after slavery outlawed

150 years after it was outlawed...

... America's first slavery museum is established in Louisiana
Kelly Clarkson: How I snubbed Simon Cowell and become a Grammy-winning superstar

Kelly Clarkson: How I snubbed Simon Cowell and become a Grammy-winning superstar

The first 'American Idol' winner on how she manages to remain her own woman – Jane Austen fascination and all
Tony Oursler on exploring our uneasy relationship with technology with his new show

You won't believe your eyes

Tony Oursler's new show explores our uneasy relationship with technology. He's one of a growing number of artists with that preoccupation
Ian Herbert: Peter Moores must go. He should never have been brought back to fail again

Moores must go. He should never have been brought back to fail again

The England coach leaves players to find solutions - which makes you wonder where he adds value, says Ian Herbert
War with Isis: Fears that the looming battle for Mosul will unleash 'a million refugees'

The battle for Mosul will unleash 'a million refugees'

Aid agencies prepare for vast exodus following planned Iraqi offensive against the Isis-held city, reports Patrick Cockburn
Yvette Cooper: We can't lose the election. There's too much on the line

Yvette Cooper: We can't lose the election. There's too much on the line

The shadow Home Secretary on fighting radical Islam, protecting children, and why anyone in Labour who's thinking beyond May must 'sort themselves out'
A bad week for the Greens: Leader Natalie Bennett's 'car crash' radio interview is followed by Brighton council's failure to set a budget due to infighting

It's not easy being Green

After a bad week in which its leader had a public meltdown and its only city council couldn't agree on a budget vote, what next for the alternative party? It's over to Caroline Lucas to find out
Gorillas nearly missed: BBC producers didn't want to broadcast Sir David Attenborough's famed Rwandan encounter

Gorillas nearly missed

BBC producers didn't want to broadcast Sir David Attenborough's famed Rwandan encounter
Downton Abbey effect sees impoverished Italian nobles inspired to open their doors to paying guests for up to €650 a night

The Downton Abbey effect

Impoverished Italian nobles are opening their doors to paying guests, inspired by the TV drama
China's wild panda numbers have increased by 17% since 2003, new census reveals

China's wild panda numbers on the up

New census reveals 17% since 2003